1.Effect of Bile Acids on Biliary Excretion of Cholesterol in Rabbits.
Sa Suk HONG ; Kyung Hwan KIM ; Won Joon KIM
Yonsei Medical Journal 1973;14(1):109-115
The effects of cholic acid and eight related cholanic acid analogs on bile flow and biliary excretion of bile salts and cholesterol were studied in rabbits. Bile acids were infused intravenously in anesthetized rabbits. In all except hyodeoxycholic or lithocholic acid treated animals increases in bile flow were recorded within 10 minutes during infusion of bile acid-The increase in bile f1ow associated with an increase in bile salt level in bile after cholic acid infusion was observed, however, there were little changes in biliary, cholesterol levels. Bile salt level in bile was not associated with bile flow after chenodeoxycholic acid infusion but the cholesterol level in bile was significantly increased. Ursodeoxycholic acid similarly increased cholesterol but to a lesser extent. Keto-forms of chenodeoxycholic acid were without action. These results indicate that both cholic and chenodeoxycholic acids have the capacity to alter specific biliary excretion of bile components, the former on bile salts and the latter on cholesterol-a precursor of bile acids in bile.
Animal
;
Bile/analysis
;
Bile/secretion*
;
Bile Acids and Salts/administration & dosage
;
Bile Acids and Salts/metabolism
;
Bile Acids and Salts/pharmacology*
;
Bilirubin/analysis
;
Cholesterol/analysis
;
Cholesterol/metabolism*
;
Cholic Acids/analogs & derivatives
;
Cholic Acids/analysis
;
Female
;
Liver/metabolism
;
Male
;
Rabbits
2.Efficacy evolution of bear bile and related research on components.
Xin-Yue LI ; Fang-Fang SU ; Chao JIANG ; Wei ZHANG ; Feng WANG ; Qing ZHU ; Guang YANG
China Journal of Chinese Materia Medica 2022;47(18):4846-4853
Animal medicine is an important part of traditional Chinese medicine(TCM). Bear bile is one of the rare animal-derived medicinal materials with the functions of clearing the liver, promoting bile secretion, calming the liver, relieving convulsions, clearing heat, and removing toxins. From the Jin Dynasty to the Tang Dynasty, bear bile was mainly used to treat internal diseases, surgical diseases, and pediatric diseases with limitations. At present, bear bile has been used to treat various diseases in pediatrics, gynecology, internal medicine, and surgery. Studies on the chemical constituents and pharmacological effects of bear bile mostly focused on bile acids. Although the non-bile acids also showed certain pharmacological effects, their mechanism of action was less investigated. At present, the source animals of bear bile are national second-class protected animals. Obtaining transformed bear bile powder through biotransformation is expected to alleviate the shortage of bear bile resources to a certain extent. Although related research on bear bile substitutes has protected bear bile resources, there are problems in functional quantification and modern interpretation. It is necessary to sort out the functions and indications of bear bile recorded in ancient books according to related modern research. This study firstly reviewed the evolution of bear bile functions and indications, analyzed the chemical components of bear bile, sorted out the relevant records of the efficacy and clinical application of bear bile in ancient books, and summarized the research progress in the safety of bear bile based on the modern pharmacological effects and clinical applications of bear bile, which is conducive to the clarification of modern efficacy and functional quantification of bear bile and the tentative exploration of the modern interpretation of bear bile.
Animals
;
Bile/metabolism*
;
Bile Acids and Salts
;
Humans
;
Medicine, Chinese Traditional
;
Powders
;
Ursidae/metabolism*
3.Lactobacillus gasseri LA39 promotes hepatic primary bile acid biosynthesis and intestinal secondary bile acid biotransformation.
Jun HU ; Qiliang HOU ; Wenyong ZHENG ; Tao YANG ; Xianghua YAN
Journal of Zhejiang University. Science. B 2023;24(8):734-748
A growing body of evidence has linked the gut microbiota to liver metabolism. The manipulation of intestinal microflora has been considered as a promising avenue to promote liver health. However, the effects of Lactobacillus gasseri LA39, a potential probiotic, on liver metabolism remain unclear. Accumulating studies have investigated the proteomic profile for mining the host biological events affected by microbes, and used the germ-free (GF) mouse model to evaluate host-microbe interaction. Here, we explored the effects of L. gasseri LA39 gavage on the protein expression profiles of the liver of GF mice. Our results showed that a total of 128 proteins were upregulated, whereas a total of 123 proteins were downregulated by treatment with L. gasseri LA39. Further bioinformatics analyses suggested that the primary bile acid (BA) biosynthesis pathway in the liver was activated by L. gasseri LA39. Three differentially expressed proteins (cytochrome P450 family 27 subfamily A member 1 (CYP27A1), cytochrome P450 family 7 subfamily B member 1 (CYP7B1), and cytochrome P450 family 8 subfamily B member 1 (CYP8B1)) involved in the primary BA biosynthesis pathway were further validated by western blot assay. In addition, targeted metabolomic analyses demonstrated that serum and fecal β-muricholic acid (a primary BA), dehydrolithocholic acid (a secondary BA), and glycolithocholic acid-3-sulfate (a secondary BA) were significantly increased by L. gasseri LA39. Thus, our data revealed that L. gasseri LA39 activates the hepatic primary BA biosynthesis and promotes the intestinal secondary BA biotransformation. Based on these findings, we suggest that L. gasseri LA39 confers an important function in the gut‒liver axis through regulating BA metabolism.
Mice
;
Animals
;
Bile Acids and Salts/metabolism*
;
Lactobacillus gasseri
;
Proteomics
;
Liver/metabolism*
;
Biotransformation
4.Advances in studies on bear bile powder.
Chao-fan ZHOU ; Guo-jian GAO ; Ying LIU
China Journal of Chinese Materia Medica 2015;40(7):1252-1258
In this paper, a detailed analysis was made on relevant literatures about bear bile powder in terms of chemical component, pharmacological effect and clinical efficacy, indicating bear bile powder's significant pharmacological effects and clinical application in treating various diseases. Due to the complex composition, bear bile powder is relatively toxic. Therefore, efforts shall be made to study bear bile powder's pharmacological effects, clinical application, chemical composition and toxic side-effects, with the aim to provide a scientific basis for widespread reasonable clinical application of bear bile powder.
Animals
;
Bile
;
chemistry
;
metabolism
;
Bile Acids and Salts
;
chemistry
;
pharmacology
;
Humans
;
Medicine, Chinese Traditional
;
Powders
;
chemistry
;
metabolism
;
pharmacology
;
Ursidae
;
metabolism
5.Bile acids and bariatric surgery.
Guangyao LIU ; Qunwei WANG ; Wei LIU
Chinese Journal of Gastrointestinal Surgery 2015;18(5):516-520
As an essential metabolic molecule, bile acids regulate triglyceride, cholesterol, energy metabolism. Bariatric surgery offers a treatment that can reduce weight and induce metabolic syndrome, but the mechanism is still unclear. New researches reveal that serum bile acids are elevated after surgery, as well as the improvement of metabolic disease. The surgery changes gastrointestinal tract, resulting in a short circuiting of the enterohepatic circulation of bile acids. Here we review the bile acids metabolism and their effect after bariatric surgery.
Bariatric Surgery
;
Bile Acids and Salts
;
Enterohepatic Circulation
;
Gastrointestinal Tract
;
Humans
;
Lipid Metabolism
;
Metabolic Syndrome
6.Effects of bile acids on expression of interleukin-6 and cell viability in QBC939 cell line.
Jian WANG ; Jia-qi DAI ; Chao-feng ZHANG
Chinese Journal of Surgery 2010;48(12):919-923
OBJECTIVETo research the effects of bile acids on the expression of interleukin-6 (IL-6) and the cell viability in QBC939 cell line.
METHODSHuman cholangiocarcinoma cells were stimulated with 800 µmol/L bile acid (CA), 100 µmol/L deoxycholate (DCA), 100 µmol/L chenodeoxycholic acid (CDCA), 1200 µmol/L gly acid (GCA), 200 µmol/L glycodeoxycholic acid (GDCA) and 300 µmol/L gly chenodeoxycholic acid (GCDCA).MTT assay and ELISA were used to detect the cell viability and the expression of IL-6 at 24 h, 48 h and 72 h.
RESULTSTreated by DCA, CDCA and GCDCA for 48 hours, the cell viability ratios changed to 0.61, 0.58 and 1.26, which were significant differences between control group and treated groups. And after 72 hours, the viability ratios of group CA, group DCA, group CDCA, group GCA, group GDCA and group GCDCA turned into 0.48, 0.50, 0.42, 1.29, 1.30 and 1.41. The differences of cell viability between bile acid-treated groups and control group were significant (P < 0.05). The expression of IL-6 in control group at 48 h and 72 h was (198 ± 32) ng/L and (323 ± 34) ng/L, while treated by CA, DCA, CDCA, GCA, GDCA and GCDCA respectively for 48 hours, the expression of IL-6 altered to (106 ± 33) ng/L, (88 ± 29) ng/L, (116 ± 54) ng/L, (413 ± 21) ng/L, (587 ± 32) ng/L and (366 ± 30) ng/L. After 72 hours, the expression of IL-6 of each bile acid-treated groups as above was (123 ± 66) ng/L, (45 ± 21) ng/L, (74 ± 45) ng/L, (792 ± 13) ng/L, (1310 ± 22) ng/L and (845 ± 18) ng/L, respectively. The differences between each bile acid-treated group and control group were significant (P < 0.05).
CONCLUSIONSFree bile acids (CA, DCA and CDCA) can inhibit the expression of IL-6 and the cell viability, while glycine conjugates (GCA, GDCA and GCDCA) can promote the expression of IL-6 and the cell viability. Bile acids can change tumor cell viability via IL-6 pathway.
Bile Acids and Salts ; pharmacology ; Bile Duct Neoplasms ; metabolism ; pathology ; Cell Line, Tumor ; Cell Survival ; drug effects ; Humans ; Interleukin-6 ; metabolism
7.Influence of Corticosteroids on the Hepatic Cell and Bile Secretion (1).
Yong Hyun KIM ; Yoo Bock LEE ; Sa Suk HONG
Yonsei Medical Journal 1969;10(1):10-18
Daily administration of glucocorticoids for 10 days to dogs resulted in a significant increase in the hepatic bile secretion in response to secretory stimulants. The response of hepatic bile in testosterone-treated animals was not changed and the response was increased in DOCA--treated animals. A significant increase of liver weight was induced by the animals receiving glucocorticoids. Other organ weight was not changed; however, a slight reduction of kidney weight was seen in prednisolone, dexamethasone, and DOCA treated animals and also in animals supplemented with cortisone following adrenalectomy. The presence of large areas of ballooning and vesicular changes of liver cells was seen in glucocorticoid treated animals, particularly in cases of dexamethasone and prednisolone. Both vesicular changes of liver cell and its glycogen content were increased by the repeated administration of prednisolone and reduced by the cessation of treatment. Special stain and liver glycogen determination demonstrated the material distending the liver cell was glycogen. These findings indicate that long term administration of glucocorticoids results in an increase of liver weight and hepatic glycogen content as well as increased bile secretion.
Animal
;
Bile/secretion*
;
Bile Acids and Salts/metabolism
;
Bilirubin/secretion
;
Cholagogues and Choleretics/pharmacology
;
Dogs
;
Glucocorticoids/pharmacology*
;
Liver/drug effects*
;
Liver/pathology
;
Liver Glycogen/metabolism
;
Organ Weight
;
Substances:
;
Bile Acids and Salts
;
Cholagogues and Choleretics
;
Glucocorticoids
;
Liver Glycogen
;
Bilirubin
8.Farnesoid X receptor regulates glucose and lipid metabolisms.
Qian JIANG ; Jun PENG ; Shuai-nan LIU ; Zhu-fang SHEN
Acta Pharmaceutica Sinica 2015;50(3):245-251
As a member of nuclear receptor superfamily, farnesoid X receptor (FXR) has been shown to regulate numerous metabolic pathways, which include playing an important role in bile acid metabolism, maintaining lipid and glucose homeostasis when FXR is activated. With the prevalence of the glucose and lipids disorder, FXR attracts increasing attention. It may be a potential target for the treatment of type 2 diabetes mellitus and lipid disorders.
Bile Acids and Salts
;
Diabetes Mellitus, Type 2
;
Glucose
;
metabolism
;
Homeostasis
;
Humans
;
Lipid Metabolism
;
Receptors, Cytoplasmic and Nuclear
;
metabolism
9.Substrate specificities of bile salt hydrolase 1 and its mutants from Lactobacillus salivarius.
Jie BI ; Fang FANG ; Yuying QIU ; Qingli YANG ; Jian CHEN
Chinese Journal of Biotechnology 2014;30(3):445-454
In order to analyze the correlation between critical residues in the catalytic centre of BSH and the enzyme substrate specificity, seven mutants of Lactobacillus salivarius bile salt hydrolase (BSH1) were constructed by using the Escherichia coli pET-20b(+) gene expression system, rational design and site-directed mutagenesis. These BSH1 mutants exhibited different hydrolytic activities against various conjugated bile salts through substrate specificities comparison. Among the residues being tested, Cys2 and Thr264 were deduced as key sites for BSH1 to catalyze taurocholic acid and glycocholic acid, respectively. Moreover, Cys2 and Thr264 were important for keeping the catalytic activity of BSH1. The high conservative Cys2 was not the only active site, other mutant amino acid sites were possibly involved in substrate binding. These mutant residues might influence the space and shape of the substrate-binding pockets or the channel size for substrate passing through and entering active site of BSH1, thus, the hydrolytic activity of BSH1 was changed to different conjugated bile salt.
Amidohydrolases
;
genetics
;
metabolism
;
Bile Acids and Salts
;
metabolism
;
Escherichia coli
;
metabolism
;
Gene Expression
;
Lactobacillus
;
enzymology
;
genetics
;
Substrate Specificity
10.Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis.
Laboratory Animal Research 2018;34(4):140-146
Though bile acids have been well known as digestive juice, recent studies have demonstrated that bile acids bind to their endogenous receptors, including Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5) and serve as hormone to control various biological processes, including cholesterol/bile acid metabolism, glucose/lipid metabolism, immune responses, and energy metabolism. Deficiency of those bile acid receptors has been reported to induce diverse metabolic syndromes such as obesity, hyperlipidemia, hyperglycemia, and insulin resistance. As consistent, numerous studies have reported alteration of bile acid signaling pathways in type II diabetes patients. Interestingly, bile acids have shown to activate TGR5 in intestinal L cells and enhance secretion of glucagon-like peptide 1 (GLP-1) to potentiate insulin secretion in response to glucose. Moreover, FXR has been shown to crosstalk with TGR5 to control GLP-1 secretion. Altogether, bile acid receptors, FXR and TGR5 are potent therapeutic targets for the treatment of metabolic diseases, including type II diabetes.
Bile
;
Bile Acids and Salts
;
Biological Processes
;
Energy Metabolism
;
Enteroendocrine Cells
;
Glucagon-Like Peptide 1*
;
Glucose
;
Homeostasis*
;
Humans
;
Hyperglycemia
;
Hyperlipidemias
;
Insulin
;
Insulin Resistance
;
Metabolic Diseases
;
Metabolism
;
Obesity